NO20025931D0 - Biotinderivater - Google Patents

Biotinderivater

Info

Publication number
NO20025931D0
NO20025931D0 NO20025931A NO20025931A NO20025931D0 NO 20025931 D0 NO20025931 D0 NO 20025931D0 NO 20025931 A NO20025931 A NO 20025931A NO 20025931 A NO20025931 A NO 20025931A NO 20025931 D0 NO20025931 D0 NO 20025931D0
Authority
NO
Norway
Prior art keywords
biotin derivative
body fluids
extracorporeal
toxic material
mammalian
Prior art date
Application number
NO20025931A
Other languages
English (en)
Other versions
NO20025931L (no
Inventor
Bengt E B Sandberg
Scott D Wilbur
Rune Nilsson
Original Assignee
Mitra Medical Technology Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0002287A external-priority patent/SE0002287D0/xx
Application filed by Mitra Medical Technology Ab filed Critical Mitra Medical Technology Ab
Publication of NO20025931D0 publication Critical patent/NO20025931D0/no
Publication of NO20025931L publication Critical patent/NO20025931L/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin, biotin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • External Artificial Organs (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20025931A 2000-06-16 2002-12-11 Biotinderivater NO20025931L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0002287A SE0002287D0 (sv) 2000-06-16 2000-06-16 Biotinderivat
US21662500P 2000-07-07 2000-07-07
PCT/SE2001/001374 WO2001095857A2 (en) 2000-06-16 2001-06-18 Reusable extracorporeal colums loaded with ligand-dibiotin conjugates

Publications (2)

Publication Number Publication Date
NO20025931D0 true NO20025931D0 (no) 2002-12-11
NO20025931L NO20025931L (no) 2003-02-14

Family

ID=26655149

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025931A NO20025931L (no) 2000-06-16 2002-12-11 Biotinderivater

Country Status (14)

Country Link
EP (1) EP1289563B1 (no)
JP (1) JP2004503299A (no)
CN (1) CN1457260A (no)
AT (1) ATE469661T1 (no)
AU (2) AU7476101A (no)
BR (1) BR0111726A (no)
CA (1) CA2412495C (no)
DE (1) DE60142286D1 (no)
HU (1) HUP0401953A3 (no)
IL (1) IL153449A0 (no)
MX (1) MXPA02012438A (no)
NO (1) NO20025931L (no)
PL (1) PL359328A1 (no)
WO (1) WO2001095857A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2374964T3 (es) * 2006-01-25 2012-02-23 Sanofi Agentes citotóxicos que comprenden nuevos derivados de tomaimicina.
HUE032930T2 (hu) 2007-11-12 2017-11-28 Chreto Aps Kettõs affinitású polipeptidek tisztításhoz
MX359217B (es) 2011-05-27 2018-09-19 Ambrx Inc Composiciones que contienen, métodos que involucran, y usos de derivados de dolastatina unidos a aminoácidos no naturales.
EP2714685B1 (en) * 2011-05-27 2016-10-19 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
CN106459089B (zh) * 2014-02-18 2021-01-08 赛威德医疗公司 生物素变体、链霉亲和素突变体以及它们的应用
CN106166311B (zh) * 2016-08-30 2018-07-13 张小曦 一种血浆净化系统及其应用
KR20210123427A (ko) * 2016-12-27 2021-10-13 에프. 호프만-라 로슈 아게 신규한 비오틴-특이적 단일클론 항체 및 그 용도
EP3584576B1 (en) * 2017-02-17 2024-05-22 Mitsui Chemicals, Inc. Bis-biotin and bis-iminobiotin derivatives as labels for identification of potential drug target proteins for development of antibody drugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100142L (sv) * 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal
US5482698A (en) * 1993-04-22 1996-01-09 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin polymer conjugates
JP3441530B2 (ja) * 1994-10-03 2003-09-02 株式会社セルシード 温度応答型分離材料及びその製造方法
JP3300583B2 (ja) * 1995-11-10 2002-07-08 幹男 中山 抗原又は抗体の検出シート、検出キット及び検出方法
WO1997029114A1 (en) * 1996-02-08 1997-08-14 Board Of Regents Of The University Of Washington Biotin-containing compounds, biotinylation reagents and methods

Also Published As

Publication number Publication date
PL359328A1 (en) 2004-08-23
WO2001095857A2 (en) 2001-12-20
IL153449A0 (en) 2003-07-06
NO20025931L (no) 2003-02-14
JP2004503299A (ja) 2004-02-05
HUP0401953A3 (en) 2005-06-28
CA2412495C (en) 2011-02-01
EP1289563B1 (en) 2010-06-02
WO2001095857A3 (en) 2002-03-28
CN1457260A (zh) 2003-11-19
BR0111726A (pt) 2003-05-27
CA2412495A1 (en) 2001-12-20
ATE469661T1 (de) 2010-06-15
DE60142286D1 (de) 2010-07-15
HUP0401953A2 (hu) 2004-12-28
MXPA02012438A (es) 2004-09-06
EP1289563A2 (en) 2003-03-12
AU2001274761B2 (en) 2005-06-16
AU7476101A (en) 2001-12-24

Similar Documents

Publication Publication Date Title
BRPI0413350A (pt) dispositivo e métodos para coleta de amostra de fluido biológico e tratamento de componentes selecionados
WO2002018652A3 (en) Method for detection of htr and htert telomerase-associated rna in plasma or serum
WO2001036977A3 (en) Identification of disease markers involving mass-based-separation
ATE440629T1 (de) Kanüleneinführungssystem
IS7842A (is) Meðferð á fettubrettusýki með eikósapentanósýru (EPA)
MXPA04000062A (es) Miembros de drenaje extensibles para conectar a tierra la proteccion por interferencia electromagnetica/interferencia por radiofrecuencia.
BRPI0417417A (pt) sistema de coleta de amostra de inibidor de fosfatase
WO2005080985A3 (en) Methods and compositions for detecting and treating autoimmune diseases
WO2004069174A3 (en) Monitoring and treatment of amyotrophic lateral sclerosis
SE0002287D0 (sv) Biotinderivat
WO2005040421A3 (en) Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
NO20025931D0 (no) Biotinderivater
WO2003092601A3 (en) A method for detecting lysosomal storage diseases
EP1365862A4 (en) ANALYZER FOR BIOLOGICAL LIQUIDS
ATE242621T1 (de) Vorrichtung zur handhabung von körperflüssigkeiten, die körperflüssigkeiten durch absaugen transportiert
BR0205439A (pt) Método e aparelho para a concentração de patógenos que se desenvolvem em fluido
WO2001048476A3 (de) Gewinnung von biologischen komponenten aus körperflüssigkeiten
WO2001063293A3 (en) Diagnosis and treatment of schizophrenia
FR2827176B1 (fr) Procede de fiabilisation de la tracabilite des prelevements sanguins lors des operations d'extraction notamment du plasma et des globules rouges
WO2003061622A3 (de) Verfahren und vorrichtumg tum einbringen von lebenden zellen in eine biologische körperflüssigkeit
DE60144027D1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
JP2000214163A5 (no)
SE0102896D0 (sv) System and method for blood analysis
WO2000050593A8 (en) Beta-tubulin autoantibody in meniere's disease and other inner ear diseases and a diagnostic method
RU2005132868A (ru) Способ заражения морских свинок при изучении биологических свойств микобактерий туберкулеза

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application